Market Place
Sourcing Support
Endo Partners Paladin Pharma to Commercialize Wynzora in Canada
15 Nov 2024 //
PR NEWSWIRE
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Glenmark gets USFDA nod for generic drug with 180-day exclusivity
23 Mar 2023 //
ECONOMIC TIMES
EPI Health, a Novan Company, and MC2 Therapeutics Present WYNZORA®
15 Sep 2022 //
GLOBENEWSWIRE
Enforcement Report - Week of July 6, 2022
06 Jul 2022 //
FDA
Glenmark receives ANDA approval for topical treatment of plaque psoriasis
09 May 2022 //
ET HEALTH
EPI Health and MC2 Therapeutics Announce Wynzora(R) Cream (calcipotriene)
09 Nov 2021 //
YAHOO
LEO Pharma announces U.S. FDA approval for Enstilar®
23 Oct 2020 //
PRESS RELEASE
PerrigoUk Finco`s Generic Betamethasone Dipropionate Receives Approval In US
15 Sep 2020 //
FDA
MC2 Therapeutics Announces FDA Approval of Wynzora® Cream
21 Jul 2020 //
B3CNEWSWIRE
Lipidor, Cadila to conduct Ph III study of anti-psoriasis candidate
07 Jul 2020 //
BIOSPECTRUMASIA
LEO Pharma Presents Results From Study of Twice-Weekly Enstilar®
12 Jun 2020 //
BUSINESSWIRE
Bicycle Therapeutics to Updated Data from PhI/IIa Trial Evaluating Lead BT1718
24 Sep 2019 //
BUSINESSWIRE
LEO Pharma Announces USFDA Expanded Regulatory Approvals for Enstilar®
31 Jul 2019 //
BUSINESSWIRE
FDA approves SORILUX(R) for Adolescent Plaque Psoriasis
23 May 2019 //
BIOSPECTRUMASIA
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
FDA approves Lupin’s generic Dovonex Scalp Solution
04 Jan 2018 //
DRUG STORE NEWS
Novel Labs Generic Calcipotriene Receives Approval In US
29 Dec 2017 //
FDA
Enforcement Report - Week of March 15, 2017
15 Mar 2017 //
FDA
Enforcement Report - Week of February 22, 2017
22 Feb 2017 //
FDA
SMC green light for LEO’s Enstilar
16 Sep 2016 //
PHARMATIMES
LEO Pharma Receives Scientific Approval of Enstilar® for the Treatment of Psoriasis in EU
21 Mar 2016 //
PR NEWSWIRE
Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
02 May 2015 //
FIERCE PHARMA MFG
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.